Rosenblatt Securities analyst Steve Frankel reiterated a Buy rating on Dolby Laboratories (DLB – Research Report) today and set a price target of $93.00. The company’s shares closed yesterday at $82.53.
Frankel covers the Technology sector, focusing on stocks such as Harmonic, Brightcove, and Avid Technology. According to TipRanks, Frankel has an average return of -1.6% and a 49.70% success rate on recommended stocks.
Currently, the analyst consensus on Dolby Laboratories is a Strong Buy with an average price target of $100.33.
See today’s best-performing stocks on TipRanks >>
DLB market cap is currently $7.74B and has a P/E ratio of 33.36.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Dolby Laboratoties, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast, and entertainment industries. Its products include Cinema Imaging, Cinema Audio, Dolby Conference Phone, Dolby Voice Room, and Other Products. The company was founded by Ray Milton Dolby in 1965 and is headquartered in San Francisco, CA.
Read More on DLB:
- Dolby Achieves Milestone of 500th Theatrical Film in Dolby Vision and Dolby Atmos with Mission: Impossible – Dead Reckoning Part One
- Dolby Laboratories Senior Vice President and Chief Financial Officer Robert Park and Senior Vice President of Entertainment John Couling to Host Fireside Chat at the J.P. Morgan Technology, Media, and Communications Conference
- Dolby Laboratories Reports Second Quarter Fiscal 2023 Financial Results
- DLB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2023 Financial Results
